Managing inpatient hyperglycaemia and initiating sodium‐glucose cotransporter 2 inhibitor therapy in the setting of diabetes and acute coronary syndrome.

We previously showed that implementing algorithms for managing diabetes in acute coronary syndrome was associated with improved inpatient glycaemic control and increased sodium‐glucose cotransporter 2 (SGLT2) inhibitor prescriptions. The present study performed 1 year later found that inpatient hyperglycaemia had relapsed to pre‐intervention rates, although SGLT2 inhibitor prescriptions remained increased. We discuss the challenges of improving inpatient glycaemic control. [ABSTRACT FROM AUTHOR]